The results confirmed that MYH9 acts as an independent oncogenic factor, affecting the proliferation, migration, and invasion of breast cancer cells, thereby corroborating our hypothesis and aligning with previous literature [18, 19] (Fig. S2C–G). Here, MYH9 is linked to breast carcinoma.